Thyroid hormone receptor -deficient mice show complete loss of the normal cholesterol 7-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol
Theres no direct interaction between tirzepatide and alcohol, but drinking can worsen nausea and other digestive side effects
Tirzepatide is an FDA-approved peptide that targets both GLP-1 and GIP receptors to regulate blood sugar, reduce appetite, and control food intake, making it highly effective for weight loss
La tirzepatida es un medicamento inyectable aprobado por la FDA para el tratamiento de la diabetes tipo 2 (como Mounjaro) y, bajo la marca Zepbound, para el manejo del peso en adultos con obesidad (IMC 30) o sobrepeso (IMC 27) con al menos una comorbilidad relacionada con el peso
It still tends to get the most attention, even though its designed for diabetes management, and weight loss is an off-label use
Secondary outcomes included the initiation of osteoporosis therapy